Cloughesy TF - Search Results

1

Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab.

Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB. Ellingson BM, et al. Among authors: cloughesy tf. Neuro Oncol. 2011 Apr;13(4):401-9. doi: 10.1093/neuonc/noq206. Epub 2011 Feb 15. Neuro Oncol. 2011. PMID: 21324937 Free PMC article.

2

Pharmacological blood-brain barrier modification for selective drug delivery.

Cloughesy TF, Black KL. Cloughesy TF, et al. J Neurooncol. 1995 Nov;26(2):125-32. doi: 10.1007/BF01060218. J Neurooncol. 1995. PMID: 8787854 Review.

3

Prolonged treatment with biologic agents for malignant glioma: a case study with high dose tamoxifen.

Cloughesy TF, Woods RP, Black KL, Couldwell WT, Law RE, Hinton DR. Cloughesy TF, et al. J Neurooncol. 1997 Oct;35(1):39-45. doi: 10.1023/a:1005895616377. J Neurooncol. 1997. PMID: 9266439

4

Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow.

Cloughesy TF, Gobin YP, Black KL, Viñuela F, Taft F, Kadkhoda B, Kabbinavar F. Cloughesy TF, et al. J Neurooncol. 1997 Nov;35(2):121-31. doi: 10.1023/a:1005856002264. J Neurooncol. 1997. PMID: 9266448 Clinical Trial.

5

Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy.

Chow KL, Gobin YP, Cloughesy T, Sayre JW, Villablanca JP, Viñuela F. Chow KL, et al. AJNR Am J Neuroradiol. 2000 Mar;21(3):471-8. AJNR Am J Neuroradiol. 2000. PMID: 10730637 Free PMC article. Clinical Trial.

6

Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma.

Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR. Gupta RK, et al. Among authors: cloughesy tf. J Neurooncol. 2000 Dec;50(3):215-26. doi: 10.1023/a:1006431120031. J Neurooncol. 2000. PMID: 11263501

7

Mapping therapeutic response in a patient with malignant glioma.

Haney SM, Thompson PM, Cloughesy TF, Alger JR, Frew AJ, Torres-Trejo A, Mazziotta JC, Toga AW. Haney SM, et al. Among authors: cloughesy tf. J Comput Assist Tomogr. 2001 Jul-Aug;25(4):529-36. doi: 10.1097/00004728-200107000-00004. J Comput Assist Tomogr. 2001. PMID: 11473181

8

Irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.

Cloughesy TF, Filka E, Nelson G, Kabbinavar F, Friedman H, Miller LL, Elfring GL. Cloughesy TF, et al. Am J Clin Oncol. 2002 Apr;25(2):204-8. doi: 10.1097/00000421-200204000-00022. Am J Clin Oncol. 2002. PMID: 11943904 Clinical Trial.

9

Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.

Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS. Choe G, et al. Among authors: cloughesy tf. Clin Cancer Res. 2002 Sep;8(9):2894-901. Clin Cancer Res. 2002. PMID: 12231534

10

Targeted molecular therapy of GBM.

Mischel PS, Cloughesy TF. Mischel PS, et al. Among authors: cloughesy tf. Brain Pathol. 2003 Jan;13(1):52-61. doi: 10.1111/j.1750-3639.2003.tb00006.x. Brain Pathol. 2003. PMID: 12580545 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters